Bausch + Lomb (NYSE:BLCO – Get Free Report) had its price objective lowered by stock analysts at Royal Bank of Canada from ...

Learn more about whether Bausch + Lomb Corporation or Inari Medical, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

After hours: January 29 at 6:13:01 PM EST Loading Chart for BLCO ...

Brent Saunders, Bausch and Lomb CEO, joins 'Money Movers' to discuss how Saunders has changed the portfolio in his time as chief executive, what the growth is like for Bausch and Lomb, and much more.

or Bausch + Lomb Corporation because you’re not sure how they ... The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and ...

City Therapeutics will develop an RNAi clinical candidate for intravitreal administration targeting retinal diseases, including geographic atrophy. Bausch + Lomb will manage IND-enabling studies, ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its fourth-quarter and full-year 2024 financial ...

Biotrue contact lens solution helps contacts stay moist and comfortable all day long. CLEANS: Biotrue contact lens solution provides exceptional cleaning. It removes dirt and protein buildup for ...